Xavier Gasull

Prof. Xavier Gasull

University of Barcelona School of Medicine and Health Sciences
+2
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2000 in Gastroenterology
Verified
Journal Article
Closed access
RBRamón Bataller
Ramón Bataller
PGPere Ginès
Pere Ginès
JNJosep M. Nicolás
Josep M. Nicolás
MGM.NIeves Görbig
M.NIeves Görbig
EGEva Garcia–Ramallo
Eva Garcia–Ramallo
JRJuan Rodés
Juan Rodés

1 December 2010 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
EDEmmanuel Deval
Emmanuel Deval
Xavier GasullXavier Gasull
Xavier Gasull
JNJacques Noël
Jacques Noël
MSMiguel SALINAS
Miguel SALINAS
ABAnne Baron
Anne Baron
ELEric Lingueglia
Eric Lingueglia

20 October 2018 in Brain
Verified
Journal Article
Closed access
MPMar Petit-Pedrol
Mar Petit-Pedrol
JSJosefine Sell
Josefine Sell
JPJesús Planagumà
Jesús Planagumà
FMFrancesco Mannara
Francesco Mannara
MRMarija Radosevic
Marija Radosevic
CGChristian Geis
Christian Geis
Leucine-rich glioma-inactivated 1 (LGI1) is a secreted neuronal protein that forms a trans-synaptic complex that includes the presynaptic disintegrin and metalloproteinase domain-containing protein 23 (ADAM23), which interacts with voltage-gated potassium channels Kv1.1, and the postsynaptic ADAM22, which interacts with AMPA receptors. Human autoantibodies against LGI1 associate with a form of autoimmune limbic encephalitis characterized by severe but treatable memory impairment and frequent faciobrachial dystonic seizures. Although there is evidence that this disease is immune-mediated, the underlying LGI1 antibody-mediated mechanisms are unknown. Here, we used patient-derived immunoglobulin G (IgG) antibodies to determine the main epitope regions of LGI1 and whether the antibodies disrupt the interaction of LGI1 with ADAM23 and ADAM22. In addition, we assessed the effects of patient-derived antibodies on Kv1.1, AMPA receptors, and memory in a mouse model based on cerebroventricular transfer of patient-derived IgG. We found that IgG from all patients (n = 25), but not from healthy participants (n = 20), prevented the binding of LGI1 to ADAM23 and ADAM22. Using full-length LGI1, LGI3, and LGI1 constructs containing the LRR1 domain (EPTP1-deleted) or EPTP1 domain (LRR3-EPTP1), IgG from all patients reacted with epitope regions contained in the LRR1 and EPTP1 domains. Confocal analysis of hippocampal slices of mice infused with pooled IgG from eight patients, but not pooled IgG from controls, showed a decrease of total and synaptic levels of Kv1.1 and AMPA receptors. The effects on Kv1.1 preceded those involving the AMPA receptors. In acute slice preparations of hippocampus, patch-clamp analysis from dentate gyrus granule cells and CA1 pyramidal neurons showed neuronal hyperexcitability with increased glutamatergic transmission, higher presynaptic release probability, and reduced synaptic failure rate upon minimal stimulation, all likely caused by the decreased expression of Kv1.1. Analysis of synaptic plasticity by recording field potentials in the CA1 region of the hippocampus showed a severe impairment of long-term potentiation. This defect in synaptic plasticity was independent from Kv1 blockade and was possibly mediated by ineffective recruitment of postsynaptic AMPA receptors. In parallel with these findings, mice infused with patient-derived IgG showed severe memory deficits in the novel object recognition test that progressively improved after stopping the infusion of patient-derived IgG. Different from genetic models of LGI1 deficiency, we did not observe aberrant dendritic sprouting or defective synaptic pruning as potential cause of the symptoms. Overall, these findings demonstrate that patient-derived IgG disrupt presynaptic and postsynaptic LGI1 signalling, causing neuronal hyperexcitability, decreased plasticity, and reversible memory deficits.

20 April 2011 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
EDEmmanuel Deval
Emmanuel Deval
JNJacques Noël
Jacques Noël
Xavier GasullXavier Gasull
Xavier Gasull
ADAnne Delaunay
Anne Delaunay
AAAbdelkrim Alloui
Abdelkrim Alloui
ELEric Lingueglia
Eric Lingueglia
Iatrogenic pain consecutive to a large number of surgical procedures has become a growing health concern. The etiology and pathophysiology of postoperative pain are still poorly understood, but hydrogen ions appear to be important in this process. We have investigated the role of peripheral acid-sensing ion channels (ASICs), which form depolarizing channels activated by extracellular protons, in a rat model of postoperative pain (i.e., hindpaw skin/muscle incision). We report high levels of ASIC-type currents (∼77%) in sensory neurons innervating the hindpaw muscles, with a prevalence of ASIC3-like currents. The ASIC3 protein is largely expressed in lumbar DRG neurons innervating the plantar muscle, and its mRNA and protein levels are increased by plantar incision 24 h after surgery. Pharmacological inhibition of ASIC3 channels with the specific toxin APETx2 orin vivoknockdown of ASIC3 subunit by small interfering RNA led to a significant reduction of postoperative spontaneous, thermal, and postural pain behaviors (spontaneous flinching, heat hyperalgesia, and weight bearing). ASIC3 appears to have an important role in deep tissue but also affects prolonged pain evoked by skin incision alone. The specific homomeric ASIC1a blocker PcTx1 has no effect on spontaneous flinching, when applied peripherally. Together, these data demonstrate a significant role for peripheral ASIC3-containing channels in postoperative pain.

1 March 2012 in Neuron
Verified
Journal Article
Closed access
EJElena Jeworutzki
Elena Jeworutzki
TLTania López-Hernández
Tania López-Hernández
XCXavier Capdevila-Nortes
Xavier Capdevila-Nortes
Sònia Sirisi DolcetSònia Sirisi Dolcet
Sònia Sirisi Dolcet
LBLuiza Bengtsson
Luiza Bengtsson
Raúl EstévezRaúl Estévez
Raúl Estévez

23 February 2011 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
GCGermán Cuesto
Germán Cuesto
LELilian Enriquez-Barreto
Lilian Enriquez-Barreto
CCCristina Caramés
Cristina Caramés
MCMarta Cantarero
Marta Cantarero
Xavier GasullXavier Gasull
Xavier Gasull
MMMiguel Morales
Miguel Morales
The possibility of changing the number of synapses may be an important asset in the treatment of neurological diseases. In this context, the synaptogenic role of the phosphoinositide-3-kinase (PI3K) signaling cascade has been previously demonstrated inDrosophila. This study shows that treatment with a PI3K-activating transduction peptide is able to promote synaptogenesis and spinogenesis in primary cultures of rat hippocampal neurons, as well as in CA1 hippocampal neuronsin vivo. In culture, the peptide increases synapse density independently of cell density, culture age, dendritic complexity, or synapse type. The induced synapses also increase neurotransmitter release from cultured neurons. The synaptogenic signaling pathway includes PI3K-Akt. Furthermore, the treatment is effective on adult neurons, where it induces spinogenesis and enhances the cognitive behavior of treated animals in a fear-conditioning assay. These findings demonstrate that functional synaptogenesis can be induced in mature mammalian brains through PI3K activation.